Ochre Bio Enters into Charitable Donation Agreement with British Liver Trust

OXFORD, England–Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, announced today to have entered into a Charitable Donation Agreement with the British Liver Trust in support of improving awareness for liver health. “On our path to develop next-generation RNA medicines with the potential to improve the lives of patients in need of a […]

Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures

OXFORD, England–Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, today announced the closing of a $9.6M seed financing round led by Khosla Ventures, with participation from Backed VC, Apollo Health Ventures, Selvedge, Hoxton and Hermes-Epitek. The funding will be used to advance the development of Ochre Bio’s RNA therapies and expand […]